NextFin news, On Monday, October 6, 2025, it was reported that the market capitalization of India's IT, pharmaceutical, and FMCG sectors reached its lowest point in 14 years during the first half of 2025. This decline is attributed primarily to the impact of increased tariffs imposed by the Trump administration and a hike in H1B visa fees, which have affected the profitability and growth prospects of these industries.
The report highlights that the US government's tariff policies and visa fee increases have created significant headwinds for Indian companies in these sectors, particularly those reliant on the US market and workforce mobility. The IT sector, which depends heavily on H1B visas for skilled labor, has been notably affected, leading to a contraction in market value.
Additionally, the pharmaceutical and FMCG sectors have experienced reduced market capitalization due to disrupted supply chains and increased costs associated with tariffs. These factors have collectively contributed to a shrinking profit pool within these traditionally strong sectors.
Conversely, the report notes an expansion in profit pools among cyclical sectors, which have benefited from shifting market dynamics and consumer behavior changes during this period. This shift underscores the evolving landscape of India's market capitalization distribution in 2025.
The analysis draws on data from the first half of 2025, emphasizing the ongoing challenges faced by Indian companies in navigating international trade policies and regulatory changes. The findings suggest that unless these external pressures ease, the affected sectors may continue to struggle with market valuation and growth.
Industry experts recommend that companies diversify their markets and invest in innovation to mitigate the risks posed by geopolitical and regulatory uncertainties. The report serves as a critical indicator for investors and policymakers to reassess strategies in light of these developments.
Explore more exclusive insights at nextfin.ai.
